Jasper Therapeutics, Inc.
JSPRNasdaqCIK 1788028HealthcareFiscal year ends Dec 31
All transactions: 2
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2024-02-08 | Carlyle Group Inc.Former 10% Owner | Purchase | 190,000 | $12.95 | $2.5m | Form 4 |
| 2023-01-27 | Carlyle Group Inc.10% owner | Purchase | 3,133,333 | $1.50 | $4.7m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.